Ankara Yildirim Beyazit University, Ankara City Hospital, Department of Infectious Disease and Clinical Microbiology, Ankara, Turkey.
University of Health Sciences, Ankara City Hospital, Department of Neurology, Ankara, Turkey.
J Infect Dev Ctries. 2024 Mar 31;18(3):480-487. doi: 10.3855/jidc.18868.
Iatrogenic botulism is a rare, serious disease that progresses with descending paralysis and develops after cosmetic or therapeutic botulinum toxin-A (BoNT-A) application.
In this case series; six cases of iatrogenic botulism followed up in our center are presented. Four of these developed after gastric BoNT-A and two after axillary BoNT-A application.
The most important cause for the disease was the use of unlicensed products and high-dose toxin applications. The first symptoms were blurred vision, double vision, difficulty in swallowing, and hoarseness. Symptoms appeared within 4-10 days after the application of BoNT-A. Symptoms progressed in the course of descending paralysis in the following days with fatigue, weakness in extremities and respiratory distress. Diagnosis was based on patient history and clinical findings. The main principles of foodborne botulism therapy were applied in the treatment of iatrogenic botulism. If clinical worsening continued, regardless of the time elapsed after BoNT-A application, the use of botulinum antitoxin made a significant contribution to clinical improvement and was recommended.
Routine and new indications for BoNT-A usage are increasing and, as a result, cases of iatrogenic botulism will be encountered more frequently. Physicians should be alert for iatrogenic botulism in the follow-up after BoNT-A applications and in the differential diagnosis of neurological diseases that are presented with similar findings.
医源性肉毒中毒是一种罕见且严重的疾病,随着进行性瘫痪的发展,在接受美容或治疗性肉毒毒素 A(BoNT-A)应用后发生。
在本病例系列中,介绍了在我们中心随访的 6 例医源性肉毒中毒病例。其中 4 例发生在胃 BoNT-A 后,2 例发生在腋窝 BoNT-A 应用后。
疾病的最重要原因是使用未经许可的产品和高剂量毒素应用。最初的症状是视力模糊、复视、吞咽困难和声音嘶哑。症状在 BoNT-A 应用后 4-10 天出现。在随后的几天里,症状随着进行性瘫痪而加重,出现疲劳、四肢无力和呼吸困难。诊断基于患者的病史和临床发现。食源性肉毒中毒的治疗主要原则适用于医源性肉毒中毒的治疗。如果临床症状持续恶化,无论在 BoNT-A 应用后多长时间,使用肉毒毒素抗毒素对临床改善有显著贡献,并被推荐使用。
BoNT-A 的常规和新适应证正在增加,因此医源性肉毒中毒的病例将更频繁地出现。医生在 BoNT-A 应用后随访时应警惕医源性肉毒中毒,并在出现类似表现的神经疾病的鉴别诊断中警惕医源性肉毒中毒。